Revision of the American Joint Committee on Cancer staging system for breast cancer. Academic Article uri icon

Overview

abstract

  • PURPOSE: To revise the American Joint Committee on Cancer staging system for breast carcinoma. MATERIALS AND METHODS: A Breast Task Force submitted recommended changes and additions to the existing staging system that were (1) evidence-based and/or consistent with widespread clinical consensus about appropriate diagnostic and treatment standards and (2) useful for the uniform accrual of outcome information in national databases. RESULTS: Major changes included the following: size-based discrimination between micrometastases and isolated tumor cells; identifiers to indicate usage of innovative technical approaches; classification of lymph node status by number of involved axillary lymph nodes; and new classifications for metastasis to the infraclavicular, internal mammary, and supraclavicular lymph nodes. CONCLUSION: This revised staging system will be officially adopted for use in tumor registries in January 2003.

publication date

  • September 1, 2002

Research

keywords

  • Breast Neoplasms
  • Neoplasm Staging

Identity

Scopus Document Identifier

  • 0036731788

Digital Object Identifier (DOI)

  • 10.1200/JCO.2002.02.026

PubMed ID

  • 12202663

Additional Document Info

volume

  • 20

issue

  • 17